Two new gene-editing tools have been created from microorganisms of the bottom of the ocean: Asterix and Obelix’s CRISPR
The new tools are highly efficient, operate at colder temperatures, and appear to be more specific than the canonical system.
The new tools are highly efficient, operate at colder temperatures, and appear to be more specific than the canonical system.
Dr. Roser Velasco, IDIBELL principal investigator at Neuro-Oncology group and neurologist at the Neuro-Oncology Unit of ICO Hospitalet and Bellvitge University Hospital, has co-directed the writing of an international guide of recommendations on the management of neurological complications associated with CAR-T cell therapy. Dr. Velasco has participated as an expert in neuro-oncology within the Committee
Megaloencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare childhood disease that mainly affects the white matter of the brain. Among other symptoms, it is characterized by macrocephaly, inability to coordinate motor movements, and epilepsy. More than 75% of diagnosed cases are due to mutations in the MLC1 gene, which encodes a protein located in
Gene therapy reverses the symptoms of a rare neurological disease in animal models Read More »
The significant increase in serious infections caused by S.dysgalactiae is confirmed, reaffirming the need to strengthen detection and surveillance systems
IDIBELL presented two talks on neuroscience research within the Pessics de Ciència cycle
The City Council will contribute €85.000 per year between 2025 and 2028.
Macrophages have a relevant role in intestinal regeneration
This month, CSIC has updated its ranking of female researchers in Spain
Exposure to high ambient temperatures is associated with lower connectivity in three brain networks in preadolescents
High temperatures could affect brain function in preadolescents Read More »
HPV research at IDIBELL-ICO receives a boost of 1.7 million euros